15 January 1994 Clinical comparison of the pharmacokinetics of m-THPC and Photofrin II as observed by light-induced fluorescence
Author Affiliations +
Proceedings Volume 2081, Optical Biopsy; (1994) https://doi.org/10.1117/12.166811
Event: Europto Biomedical Optics '93, 1993, Budapest, Hungary
Abstract
To optimize phototherapy and photodetection of cancer, one of the important variables is the localization of the dye after injection. To study this in a clinical context, we have constructed an apparatus based on a non-invasive optical fiber that detects the dye by light induced fluorescence. The time course of the fluorescence signal can be used directly for optimizing photodetection. However, complementary information on the detailed localization of the drug by fluorescence microscopy, and a correlation of this data with tumor necrosis efficacy, are necessary to optimize PDT timing. This will be demonstrated for the case of Photofrin II and tetra (meta- hydroxyphenyl) chlorin (mTHPC) and the two sets of data will be compared.
© (1994) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Daniel Braichotte, Daniel Braichotte, Jean-Francois Savary, Jean-Francois Savary, Georges A. Wagnieres, Georges A. Wagnieres, A. Mudry, A. Mudry, Charlotte Fontolliet, Charlotte Fontolliet, Philippe Monnier, Philippe Monnier, Hubert van den Bergh, Hubert van den Bergh, } "Clinical comparison of the pharmacokinetics of m-THPC and Photofrin II as observed by light-induced fluorescence", Proc. SPIE 2081, Optical Biopsy, (15 January 1994); doi: 10.1117/12.166811; https://doi.org/10.1117/12.166811
PROCEEDINGS
12 PAGES


SHARE
Back to Top